News from Aragon Pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

04 Oct, 2012, 08:00 ET Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers

 Aragon Pharmaceuticals Inc. today announced that the company has raised $50 million in a Series D financing to advance the company's pipeline...


01 Oct, 2012, 08:00 ET Aragon Pharmaceuticals Announces Clinical Results from Ongoing Phase II Trial Confirming Robust Anti-Tumor Activity and Tolerability of ARN-509 in Three Different Patient Populations of Castration Resistant Prostate Cancer

Aragon Pharmaceuticals Inc., a leader in developing drugs for hormone driven cancers, announced new data from an ongoing, open-label, multicenter...


28 Aug, 2012, 08:00 ET Aragon Pharmaceuticals Announces Appointment of Faheem Hasnain as Independent Director

Aragon Pharmaceuticals today announced the appointment of Faheem Hasnain as an independent director of the Company's board of directors. Mr....


06 Mar, 2012, 07:00 ET Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers

 Aragon Pharmaceuticals today announced that the company has secured $42 million in an oversubscribed Series C financing to advance Aragon's...


02 Aug, 2010, 08:00 ET Aragon Pharmaceuticals Appoints Richard A. Heyman CEO

Aragon Pharmaceuticals today announced the appointment of company co-founder Richard A. Heyman, Ph.D., to the role of Chief Executive Officer....


20 May, 2009, 10:30 ET Aragon Pharmaceuticals Announces $8 Million Series A Financing

Aragon Pharmaceuticals today announced it has raised $8 million in Series A financing led by The Column Group and OrbiMed Advisors. Funds from the...